Pharma Pulse 11/12/24: Biotech Investor Sentiment Climbing Steadily, Vaccination Community Outreach Initiatives & more
The latest news for pharma industry insiders.
Biotech Investor Sentiment Climbing Steadily, with Growing Enthusiasm Heading into 2025
The sector's XBI is up 15% year-to-date; rate cuts, election outcome, and M&A are viewed as tailwinds.
Vaccination Community Outreach Initiatives
Carrie Koenigsfeld, PharmD, FAPhA, discusses examples of successful community outreach initiatives aimed at overcoming barriers to adult RSV vaccination.
From AI to Hardware Costs: Enterprise Tech Leaders Prepare for Trump 2.0
The president-elect’s focus on tariffs and reducing regulation could affect hardware costs and AI deployments, and set off an M&A frenzy, CIOs say.
Care Access is bringing its Heart & Kidney Health Screening initiative to Philadelphia, Pa. This health screening aims to raise awareness and provide testing for certain health risk factors, including a dangerous type of cholesterol known as lipoprotein(a), or Lp(a), which impacts one in five people and significantly increases the risk of heart disease and stroke.
Blake Powers on LinkedIn
My second column "Dusting Off One's Cost Center Hat" just published - it speaks to why you might be hearing pharmacies cry the reimbursement blues, and what they'll have to do as businesses to continue serving patients.https://lnkd.in/euctUrwD
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs
